Navigation Links
Dr. Daniel Von Hoff presented with top genomics award from Scripps
Date:3/17/2011

LA JOLLA, Calif. March 17, 2011 Dr. Daniel Von Hoff was presented this month with the Scripps Genomic Medicine Award for his "pioneering efforts" in sequencing, or spelling out, the DNA of patients with rare cancers.

Dr. Von Hoff's research and clinical work advances the art of using the fully sequenced genomes of cancer patients, spelling out all 3 billion letters of their DNA, to help determine the best course of treatment.

"I am extremely humbled and honored to receive this award on behalf of all the institutes, medical centers and oncology groups I'm associated with. Through this work, we are trying to improve things for every patient," said Dr. Von Hoff, who holds the titles of Physician-in-Chief and Distinguished Professor at the Translational Genomics Research Institute (TGen); Professor of Medicine at both Mayo Clinic and at the University of Arizona College of Medicine; and Chief Scientific Officer at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and at US Oncology.

Dr. Von Hoff is recognized as one of the world's leading authorities on pancreatic cancer. Some of his most recent work involves the comparative analysis of the fully sequenced genomes of patients with rare cancers and with triple-negative breast cancer, identifying the mutations in the DNA of the patients' tumors and using that information to help guide future treatment of this rare and challenging disease.

Dr. Eric J. Topol, Director of the Scripps Translational Science Institute (STSI), presented the Genomic Medicine award to Dr. Von Hoff, citing his "pioneering efforts" in whole genome sequencing as a tool for matching a patient's genetic makeup with treatments that will provide the best quality of life.

"Dr. Von Hoff's work represents the future of medicine, in which information gleaned from the complex assemblage of an individual's DNA can be used to target deadly tumors, even among patients with rare cancers," said Dr. Topol, who also is Chief Academic Officer of Scripps Health, and Professor of Translational Genomics at the Scripps Research Institute.

The award was presented to Dr. Von Hoff during the Future of Genomic Medicine IV conference, March 3-4, at the Robert Paine Scripps Forum for Science, Society and the Environment, Samuel H. Scripps Auditorium, in La Jolla, Calif.

Physicians, health care professional, human geneticists, genomic scientists and researchers attended the conference. This fourth installment of the Future of Genomic Medicine conference focused on the extraordinary advances occurring in the field, including whole genome and exome sequencing, new gene expression tests for routine medical practice, and consumer genomics. The overarching goal of the annual conference is to spearhead efforts to change medicine by using genomics.

Like all who work with Dr. Von Hoff, the STSI aims to replace the status quo of one-size-fits-all-medicine with individualized health care that is based on the known genetic factors influencing health and disease.

Under the leadership of Dr. Topol, one of the world's premier cardiologists and physician/scientists, STSI has created major programs in both research and education-training that bridge science with medicine, and academia with industry.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Cell biologist Daniel Gottschling elected to American Academy of Arts & Sciences
2. UTHealth, Athersys preclinical research on stem cell therapy for stroke presented at AHA conference
3. Chimerix Antiviral CMX001 Inhibits JC Virus Replication in Preclinical Study; Late-Breaker Presented at Antiviral Congress 2010
4. LungPoint system results presented at American Thoracic Society 2010 International Conference
5. Selected highlights of the research being presented at the Experimental Biology 2010 meeting
6. Latest research on GI health presented at DDW 2010
7. Early detection of lung cancer: New data presented at multidisciplinary meeting
8. IADR Wilmer Souder Award presented to University of Colorado professor
9. World Energy Outlook to be presented at Rice University Dec. 9
10. New cardiology research presented at CHEST 2008
11. DOE JGI Genomics of Energy & Environment Meeting set for March 22-24, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:2/28/2017)... 2017 News solutions for biometrics, bag drop ... ... 14 to 16 March, Materna will present its complete end-to-end ... travel is a real benefit for passengers. To accelerate the ... passenger touch point solutions to take passengers through the complete ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... March 29, 2017  Vermillion, Inc. (NASDAQ: VRML), ... reported on its results for the fourth quarter ... "2016 marked a pivotal year for us ... inclusion, international distribution agreements, major reimbursement progress with ... payer agreements. In addition we cleared our 2 ...
(Date:3/29/2017)... 29, 2017 WuXi Biologics, a leading ... to biologics and a WuXi AppTec Affiliate, today ... Best Bioprocessing Excellence Award from IMAPAC, a leading ... aims to recognize outstanding leaders and trend-setters of ... bioprocessing and biomanufacturing experts in the industry, along ...
(Date:3/29/2017)... LINCOLN, Mass. , March 29, 2017 ... industry-leader in applying mechanistic modeling to drug ... of their collaboration with Zymeworks Inc. for ... drug conjugate therapeutics intended for the treatment ... has supported Zymeworks previously for GLP toxicology ...
(Date:3/29/2017)... ... March 29, 2017 , ... Cancer diagnostics and pathology workflow ... at the Association of Community Cancer Centers (ACCC) 43rd Annual Meeting, CANCERSCAPE ... unites key stakeholders from leading national organizations to share insights on how value-based ...
Breaking Biology Technology: